|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 98, 1113-1121, Copyright © 1989 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
G Laufer, J Miholic, A Laczkovics, G Wollenek, C Holzinger, A Hajek-Rosenmeier, G Wuzl, W Schreiner, P Buxbaum and E Wolner
To assess independent risk factors predicting the occurrence of clinically
significant acute rejection episodes in the first 6 months after cardiac
transplantation, we performed a multivariate stepwise logistic regression
analysis. Forty-three recipients, undergoing transplantation between
September 1986 and May 1988, were eligible for analysis and received
standardized, low-dose triple drug maintenance immunosuppression with
cyclosporine, azathioprine, and prednisolone. Immunoprophylaxis was
supplemented perioperatively with either a polyclonal (antithymocyte
globulin, N = 26) or a monoclonal (OKT3, N = 17) anti-T-cell antibody.
Investigated, conceivable risk factors comprised recipient and donor age,
ischemic time, perioperative anti-T- cell antibody prophylaxis, recipient
preoperative status, underlying disease, previous cardiac operation, and
histocompatibility parameter (mismatches for HLA-A, HLA-B, HLA-DR,
HLA-B+DR, HLA-A+B+DR, and Rh0[D] antigen, HLA-DRw6 positive recipient, and
identify for ABO system). Univariate analysis suggested significant
influence of the type of antibody used perioperatively (p = 0.0024) and the
number of mismatches for HLA-A+B+DR (p = 0.0037) and for HLA-B+DR (p =
0.0043). Stepwise logistic regression yielded the number of mismatches for
HLA-B+DR (p = 0.0029) and the type of antibody used perioperatively (p =
0.0031) as being highly significant predictors of acute cardiac rejection.
Six- month freedom from rejection was 100%, 41%, and 27% for recipients
with two, three, and four mismatches for HLA-B+DR and 59% versus 22% for
recipients with polyclonal versus monoclonal antibody prophylaxis. Similar
to results with kidney transplantation, these results indicate that a poor
donor/recipient match for combined HLA-B+DR loci constitutes an independent
risk factor for acute graft rejection in low- dose triple drug
immunosuppressed cardiac recipients, which stimulates the potential concept
of prospective HLA matching. In our experience OKT3 prophylaxis provides
significantly less effective prevention of acute rejection than a
comparable course of antithymocyte globulin.
ARTICLES
Independent risk factors predicting acute graft rejection in cardiac transplant recipients treated by triple drug immunosuppression
Department of Surgery II, University of Vienna, Austria.
This article has been cited by other articles:
![]() |
C. Blanche, A. Kamlot, D. A. Blanche, B. Kearney, A. V. Wong, L. S. C. Czer, and A. Trento Combined heart-kidney transplantation with single-donor allografts J. Thorac. Cardiovasc. Surg., September 1, 2001; 122(3): 495 - 500. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Flippin, D. T. Balzer, P. R. Murphy, S. E. Ruble, E. N. Mendeloff, C. B. Huddleston, and C. E. Canter Rejection with heart failure after pediatric cardiac transplantation Ann. Thorac. Surg., July 1, 1999; 68(1): 176 - 180. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Wechsler, E.-G. V. Giardina, R. R. Sciacca, E. A. Rose, and M. L. Barr Increased Early Mortality in Women Undergoing Cardiac Transplantation Circulation, February 15, 1995; 91(4): 1029 - 1035. [Abstract] [Full Text] |
||||
![]() |
C. Blanche, M. Valenza, L. S. C. Czer, P. Barath, D. Admon, D. Harasty, C. Utley, and A. Trento Combined heart and kidney transplantation with allografts from the same donor Ann. Thorac. Surg., October 1, 1994; 58(4): 1135 - 1138. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |